Publications by authors named "Torben Balchen"

Claim this Profile
A
A First-in-Human Randomized Clinical Study Investigating the Safety and Tolerability of Stabilized Hypochlorous Acid in Patients with Chronic Leg Ulcers.
Magnus Mustafa Fazli, Klaus Kirketerp-Møller, David Peick Sonne, Torben Balchen, Glenn Gundersen

Adv Wound Care (New Rochelle)· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose safety and pharmacodynamics of subcutaneous bupivacaine in a novel extended-release microparticle formulation: A phase 1, dose-ascending study in male volunteers.
Elisabeth Kjær Jensen, Søren Bøgevig, Torben Balchen, Anders Holten Springborg, Mike Allan Royal

Basic Clin Pharmacol Toxicol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetic-pharmacodynamic model of subcutaneous bupivacaine in a novel extended-release microparticle formulation.
Ida Klitzing Storgaard, Elisabeth Kjær Jensen, Søren Bøgevig, Torben Balchen, Anders Holten Springborg

Basic Clin Pharmacol Toxicol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, Tolerability, and Pharmacodynamics of the ADAMTS-5 Nanobody M6495: Two Phase 1, Single-Center, Double-Blind, Randomized, Placebo-Controlled Studies in Healthy Subjects and Patients With Osteoarthritis.
Asger Reinstrup Bihlet, Torben Balchen, Kosalaram Goteti, Jesper Sonne, Christoph Ladel

ACR Open Rheumatol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, double-blind, placebo-controlled phase 1 trial of inhaled and intranasal niclosamide: A broad spectrum antiviral candidate for treatment of COVID-19.
Vibeke Backer, Ulf Sjöbring, Jesper Sonne, Anne Weiss, Morten Hostrup, Torben Balchen

Lancet Reg Health Eur· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccination against RhoC induces long-lasting immune responses in patients with prostate cancer: results from a phase I/II clinical trial.
Juliane Schuhmacher, Sonja Heidu, Torben Balchen, Jennifer Rebecca Richardson, Camilla Schmeltz

J Immunother Cancer· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tinzaparin and other low-molecular-weight heparins: what is the evidence for differential dependence on renal clearance?
Kristian B Johansen, Torben Balchen

Exp Hematol Oncol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tolerability and pharmacokinetics of TB-402 in healthy male volunteers.
Peter Verhamme, Steve Pakola, Thomas J Jensen, Kristina Berggren, Elisabeth Sonesson, Torben Balchen

Clin Ther· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis